CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$10.68
52W Range
$6.71 - $896.00
50D Avg
$12.10
200D Avg
$104.34
Market Cap
$4.93M
Avg Vol (3M)
$1.16M
Beta
0.43
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.